MedTrace Logo

Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh

NCT04779918 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-05-05

No results posted yet for this study

Summary

This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.

Conditions

  • Hernia, Ventral
  • Hernia, Inguinal

Interventions

DEVICE

OviTex Reinforced Tissue Matrix

All study subjects will receive OviTex. All OviTex Reinforced Tissue Matrices are intended for use as a surgical mesh to reinforce or repair soft tissue where weakness exists.

Sponsors & Collaborators

  • MCRA

    collaborator INDUSTRY

  • Tela Bio Inc

    lead INDUSTRY

Principal Investigators

  • Geoffrey Slayden, MD · St. Lukes Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2027-03-30
Completion
2029-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04779918 on ClinicalTrials.gov